Literature DB >> 20031054

Cluster of serogroup W135 meningococci, southeastern Florida, 2008-2009.

Timothy J Doyle1, Alvaro Mejia-Echeverry, Paul Fiorella, Fermin Leguen, John Livengood, Robyn Kay, Richard Hopkins.   

Abstract

Recently, 14 persons in southeastern Florida were identified with Neisseria meningitidis serogroup W135 invasive infections. All isolates tested had matching or near-matching pulsed-field gel electrophoresis patterns and belonged to the multilocus sequence type 11 clonal complex. The epidemiologic investigation suggested recent endemic transmission of this clonal complex in southeastern Florida.

Entities:  

Mesh:

Year:  2010        PMID: 20031054      PMCID: PMC2874373          DOI: 10.3201/eid1601.091026

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Neisseria meningitidis serogroup W135, which generally accounts for <5% of invasive meningococcal disease in the United States, has frequently been associated with foreign travel and is less often associated with outbreaks than other serogroups (). In Florida during 2004–2007, a total of 337 patients statewide were reported to have meningococcal disease; 6 (1.8%) of these were caused by serogroup W135.

The Study

Meningococcal disease is a reportable condition in Florida. Isolates of N. meningitidis from persons with invasive disease are forwarded to the state health department Bureau of Laboratories for serogrouping by slide agglutination. Isolates from outbreaks or clusters are further characterized by pulsed-field gel electrophoresis (PFGE) by using NheI and SpeI restriction enzymes and methods consistent with standard protocols (). From December 2008 through April 2009, we observed an increase of invasive meningococcal disease caused by serogroup W135 in southeastern Florida totaling 13 patients, of whom 9 had indistinguishable PFGE patterns (Figure 1). Isolates from the 4 other case-patients had PFGE patterns differing by 1 (pattern II), 2 (pattern III), and 5 bands (pattern IV), making them >94% related to the dominant pattern. A retrospective review of all 5 W135 isolates in Florida from January 2007 through November 2008 identified 1 additional isolate matching the dominant pattern from a resident of southeastern Florida with illness onset in May 2008. The 4 other isolates from 2007–2008 had PFGE patterns <80% related (Figure 1) and occurred before May 2008 in residents of central and northern Florida.
Figure 1

Pulsed-field gel electrophoresis (PFGE) patterns for 14 related and 4 unrelated isolates of Neisseria meningitidis serogroup W135, Florida, USA.

Pulsed-field gel electrophoresis (PFGE) patterns for 14 related and 4 unrelated isolates of Neisseria meningitidis serogroup W135, Florida, USA. Of the 14 case-patients with matching or near-matching PFGE patterns (Table 1), 13 denied recent foreign travel. One patient with disease onset in April 2009 was a tourist visiting Miami from the United Kingdom. Eleven (79%) case-patients resided in or were visiting Miami-Dade County, 2 (14%) resided in Broward County, and 1 (7%) was a resident of Palm Beach County. Of the 14 case-patients, the median age was 45 years (range 1–84). Eight (57%) case-patients were female, 7 (50%) were Hispanic; 8 were white, and 6 were black. Twelve patients had a bacteremia syndrome, 2 had meningitis, and 1 had pneumonia in addition to bacteremia. Four of 14 patients died, all with bacteremia. The epidemiologic investigation has not identified any common exposures, social settings, or other connections among patients in this series. Six (43%) case-patients had onset of illness within 10 days of their birthdays (binomial probability, p<0.0001), but no obvious detailed exposures were identified related to this observation.
Table 1

Demographic and clinical characteristics of patients with serogroup W135 meningococcal disease, southeastern Florida, USA, 2008–2009*

Case IDAge, y/ sexRaceHispanic ethnicityCountyMonth of onsetOnset near birthday†SyndromeSpecimen sourceOutcomePFGE group
139/MWhiteYBroward2008 MayYBBloodSurvived1
21/MWhiteYMiami-Dade2008 DecYMCSFSurvived1
329/MWhiteYPalm Beach2009 JanNMCSFSurvived1
483/MWhiteYMiami-Dade2009 JanYB, PBloodDied1
584/FWhiteYMiami-Dade2009 JanNBBloodSurvived1
626/FBlackNMiami-Dade2009 JanYBBloodSurvived1
770/MWhiteYMiami-Dade2009 FebNBBloodSurvived1
850/FBlackNMiami-Dade2009 FebNBBloodSurvived1
977/FBlackNMiami-Dade2009 FebNBBloodSurvived2
1058/FBlackNBroward2009 MarYBBloodDied4
1120/FWhiteNMiami-Dade2009 MarNBBloodDied1
1269/FWhiteYMiami-Dade2009 AprNBBloodSurvived4
1326/FBlackNMiami-Dade‡2009 AprYBBloodDied3
1419/MBlackNMiami-Dade2009 AprNBBloodSurvived1

*ID, identification; PFGE, pulsed-field gel electrophoresis; B, bacteremia; M, meningitis; CSF, cerebrospinal fluid; P, pneumonia.
†Within 10 days, before or after.
‡Foreign tourist visitor to Miami-Dade County.

*ID, identification; PFGE, pulsed-field gel electrophoresis; B, bacteremia; M, meningitis; CSF, cerebrospinal fluid; P, pneumonia.
†Within 10 days, before or after.
‡Foreign tourist visitor to Miami-Dade County. Illness onset for the 14 W135 patients in this cluster is shown in relation to onset for all 38 meningococcal disease patients with other serogroups identified in Florida during the same 12-month period (Figure 2). Demographic and clinical factors were also compared between these serogroup W135 and non-W135 patients (Table 2). As a group, serogroup W135 patients were older, were more likely to be Hispanic and to reside in or be visiting the southeastern 3-county region, were more likely to have bacteremia, and had higher mortality rates than non-W135 serogroup patients. However, other than Hispanic ethnicity and residence in the southeastern region, none of these differences were significant.
Figure 2

Confirmed meningococcal disease cases, by month of onset, Florida, USA, May 2008–April 2009.

Table 2

Characteristics of patients with serogroup W135 and non-W135 meningococcal disease, Florida, USA, May 2008–April 2009

VariableNo. positive/no. tested (%)
p value*
W135, 
n = 14Non-W135, 
n = 38
Female sex8/14 (57)22/38 (58)1.00
White race8/14 (57)30/38 (79)0.16
Hispanic ethnicity7/14 (50)7/38 (18)0.04
Residence in southeast region14/14 (100)12/38 (32)<0.0001
Bacteremia12/14 (86)24/38 (63)0.18
Meningitis2/14 (14)13/38 (34)0.30
Pneumonia1/14 (7)5/38 (13)1.00
Death4/14 (29)4/38 (11)0.19

*By 2-sided Fisher exact test used for categorical variables; Wilcoxon rank-sum test used for age. Median age for W135 patients, 45 years; median age for non-W135 patients, 27 years; p value = 0.07.

Confirmed meningococcal disease cases, by month of onset, Florida, USA, May 2008–April 2009. *By 2-sided Fisher exact test used for categorical variables; Wilcoxon rank-sum test used for age. Median age for W135 patients, 45 years; median age for non-W135 patients, 27 years; p value = 0.07. Twelve isolates from the Florida cluster were forwarded to Centers for Disease Control and Prevention laboratories for antimicrobial susceptibility testing. All 12 isolates were sensitive to all antimicrobial agents tested (penicillin G, ceftriaxone, ciprofloxacin, rifampin, azithromycin). Seven of these isolates underwent additional molecular characterization with PCR and multilocus sequence typing by using methods previously described (,). The isolates were confirmed as serogroup W135 by real-time PCR with primers specific for serogroups A, B, C, W135, X, and Y. These isolates were also found to belong to the sequence type (ST)-11/electrophoretic type 37 clonal complex. The dominant PFGE pattern seen in the Florida cluster is designated H46N06.0068, and is closely related to the pattern observed in the large multicountry outbreak associated with Hajj pilgrims occurring in 2000 (). The 2000 outbreak involved >400 cases and was caused by a single clone of the ST-11 clonal complex. In recent years, increases in serogroup W135 have been noted in northern Argentina () and southern Brazil (). Among serogroup W135 isolates in these countries, the most common clone has been the hypervirulent ST-11 complex (,). From 1997 through 2006, the annual incidence of meningococcal disease in Florida declined gradually from ≈1.2 to 0.4 cases per 100,000 population (). Historical trends of surveillance data in Florida suggest seasonal peaks of meningococcal disease during November–May, corresponding to the winter dry season, when tourist visitors and part-time residents are most likely to visit. The 3-county region of southeastern Florida in which this W135 cluster occurred had an estimated population in 2008 of >5.5 million inhabitants; 2.4 million of these reside in Miami-Dade County, where >60% of residents are Hispanic. During December 2008 through April 2009, the 32 total patients with meningococcal disease reported in the state represent an annual incidence of 0.41 cases/100,000 Florida residents. The 19 total cases (13 serogroup W135) in the 3-county region during this period represent an annual population incidence of 0.82 cases/100,000 residents in these counties. For the 13 total cases occurring in Miami-Dade County during this period (11 serogroup W135), the annual incidence would be 1.26 cases/100,000 residents in the county. During May 2009, no cases of serogroup W135 meningococcal disease were reported anywhere in the state. In the absence of a more narrowly defined risk group, the cluster of serogroup W135 case-patients described in this report is still far below the threshold for recommending vaccination control efforts (10 cases/100,000 over 3 months) ().

Conclusions

Southeastern Florida is considered the gateway to the Americas, with extensive social, cultural, and commercial ties to Central and South America and the Caribbean. The dominant clonal complex observed in the Florida cluster matches the dominant type recently observed in Argentina and Brazil, raising the possibility of introduction to southeastern Florida from South America. Taken together, these observations suggest the possible establishment of a clonal complex of serogroup W135 meningococci in southeastern Florida with subsequent endemic transmission.
  6 in total

1.  Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex.

Authors:  Leonard W Mayer; Michael W Reeves; Nasser Al-Hamdan; Claudio T Sacchi; Muhamed-Kheir Taha; Gloria W Ajello; Susanna E Schmink; Corie A Noble; Maria Lucia C Tondella; Anne M Whitney; Yagoub Al-Mazrou; Mohammed Al-Jefri; Amin Mishkhis; Sameer Sabban; Dominique A Caugant; Jairam Lingappa; Nancy E Rosenstein; Tanja Popovic
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

2.  W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina.

Authors:  Adriana M Efron; Cecilia Sorhouet; Celia Salcedo; Raquel Abad; Mabel Regueira; Julio A Vázquez
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

3.  Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C.

Authors:  T Popovic; S Schmink; N A Rosenstein; G W Ajello; M W Reeves; B Plikaytis; S B Hunter; E M Ribot; D Boxrud; M L Tondella; C Kim; C Noble; E Mothershed; J Besser; B A Perkins
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Oleg O Bilukha; Nancy Rosenstein
Journal:  MMWR Recomm Rep       Date:  2005-05-27

5.  Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.

Authors:  Don Weiss; Eric J Stern; Christopher Zimmerman; Brooke Bregman; Alice Yeung; Debjani Das; Catherine M Dentinger; Melissa A Marx; John Kornblum; Lillian Lee; Tanya A Halse; Leonard W Mayer; Cynthia P Hatcher; M Jordan Theodore; Susanna Schmink; Brian H Harcourt; Jane R Zucker; Marci Layton; Thomas A Clark
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

6.  High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.

Authors:  Luciana Weidlich; Ludmila F Baethgen; Leonard W Mayer; Camile Moraes; Cecília C Klein; Luciana S Nunes; Sílvia da S Rios; Claudete I Kmetzsch; Maria L R Rossetti; Arnaldo Zaha
Journal:  J Infect       Date:  2008-09-23       Impact factor: 6.072

  6 in total
  9 in total

Review 1.  The changing epidemiology of meningococcal disease in North America 1945-2010.

Authors:  Carmen Baccarini; Andrew Ternouth; Heather Wieffer; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

2.  Population structure of invasive Neisseria meningitidis in the United States, 2011-15.

Authors:  Caelin C Potts; Sandeep J Joseph; How-Yi Chang; Alexander Chen; Jeni Vuong; Fang Hu; Laurel T Jenkins; Susanna Schmink; Amy Blain; Jessica R MacNeil; Lee H Harrison; Xin Wang
Journal:  J Infect       Date:  2018-06-30       Impact factor: 6.072

3.  Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis.

Authors:  Mustapha M Mustapha; Jane W Marsh; Mary G Krauland; Jorge O Fernandez; Ana Paula S de Lemos; Julie C Dunning Hotopp; Xin Wang; Leonard W Mayer; Jeffrey G Lawrence; N Luisa Hiller; Lee H Harrison
Journal:  EBioMedicine       Date:  2015-09-08       Impact factor: 8.143

4.  Emergence of Localized Serogroup W Meningococcal Disease in the United States - Georgia, 2006-2016.

Authors:  Ashley E Moore; Jessica R MacNeil; Xin Wang; Sandeep J Joseph; Lauren Lorentzson; Stepy Thomas; Amy Tunali; Tonia Parrott; Monica M Farley; Melissa Tobin-D'Angelo
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-17       Impact factor: 17.586

5.  Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010.

Authors:  Ana Belén Ibarz-Pavón; Ana Paula Lemos; Maria Cecilia Gorla; Mabel Regueira; Jean-Marc Gabastou
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

6.  Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America.

Authors:  R Abad; E L López; R Debbag; J A Vázquez
Journal:  Epidemiol Infect       Date:  2014-05-15       Impact factor: 4.434

7.  Spread of Neisseria meningitidis serogroup W clone, China.

Authors:  Haijian Zhou; Wei Liu; Li Xu; Lili Deng; Qiuyun Deng; Jiatong Zhuo; Zhujun Shao
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

8.  Neisseria meningitidis serogroup W135 sequence type 11, Anhui Province, China, 2011-2013.

Authors:  Shoukui Hu; Wenyan Zhang; Furong Li; Zhongwang Hu; Erjian Ma; Tianli Zheng; Yingying Zhao; Wei Li; Haijian Zhou; Zhujun Shao; Jianguo Xu
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

Review 9.  A Review of Meningococcal Disease and Vaccination Recommendations for Travelers.

Authors:  Lidia C Serra; Laura J York; Amgad Gamil; Paul Balmer; Chris Webber
Journal:  Infect Dis Ther       Date:  2018-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.